RhumbLine Advisers’s Palvella Therapeutics PVLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $224K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $339 | Hold |
|
|||||
|
2023
Q3 | $556 | Hold |
|
|||||
|
2023
Q2 | $309 | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $162K | Buy |
|
|||||
|
2020
Q4 | $157K | Buy |
|
|||||
|
2020
Q3 | $122K | Sell |
|
|||||
|
2020
Q2 | $209K | Buy |
|
|||||
|
2020
Q1 | $144K | Hold |
|
|||||
|
2019
Q4 | $229K | Buy |
|
|||||
|
2019
Q3 | $214K | Sell |
|
|||||
|
2019
Q2 | $298K | Sell |
|
|||||
|
2019
Q1 | $221K | Sell |
|
|||||
|
2018
Q4 | $178K | Buy |
|
|||||
|
2018
Q3 | $247K | Sell |
|
|||||
|
2018
Q2 | $241K | Buy |
|
|||||
|
2018
Q1 | $226K | Buy |
|
|||||
|
2017
Q4 | $230K | Sell |
|
|||||
|
2017
Q3 | $216K | Buy |
|
|||||
|
2017
Q2 | $184K | Buy |
|